MMP12 and achalasia-alacrima syndrome: Concurrent in situ zymography in the presence of a selective MMP-12 inhibitor (RXP470.1) confirmed that MMP-12 activity is responsible for the majority of elastinolytic activity within human AAAs (Figure 1F,G).